I mpairment of arterial baroreflex sensitivity for heart rate and blood pressure has adverse prognostic significance in patients with chronic heart failure (CHF) [1] [2] [3] [4] [5] and in a variety of experimental models of CHF. 6, 7 The arterial baroreflex arc consists of an afferent limb (baroreceptor neurons), a central neural component, and an autonomic efferent component. Any component of the arterial baroreflex arc could be responsible for the attenuated baroreflex sensitivity in CHF state. Data from 1 research group have demonstrated that chronic electric stimulation of the baroreceptors improves the survival rate in dogs with pacing-induced CHF. 8 Our previous study demonstrated that expression and activation of the voltage-gated sodium (Na v ) channels are decreased in the baroreceptor neurons from CHF rats. 9 The Na v channel dysfunction reduces cell excitability of the baroreceptor neurons and subsequently contributes to the blunted baroreflex sensitivity in the CHF rats. 9 Our recent study demonstrated that elevation of the mitochondria-derived superoxide lowers expression and activation of the Na v channels in the baroreceptor neurons from CHF rats. 10 However, it is unclear how the superoxide modulates the expression and activation of the Na v channels in the baroreceptor neurons from CHF rats.
Nuclear factor κB (NFκB) is a transcription factor that can regulate the expression of a number of genes involved in disease states, such as inflammatory disease and heart failure. [11] [12] [13] [14] NFκB consists of 5 structurally related proteins, namely RelA (p65), RelB, c-Rel, p50, and p52. The p65/p50 heterodimer is the most abundant and widely expressed form Abstract-Arterial baroreflex sensitivity is attenuated in chronic heart failure (CHF) state, which is associated with cardiac arrhythmias and sudden cardiac death in patients with CHF. Our previous study showed that CHF-induced sodium channel dysfunction in the baroreceptor neurons was involved in the blunted baroreflex sensitivity in CHF rats. Mitochondria-derived superoxide overproduction decreased expression and activation of the sodium channels in the baroreceptor neurons from CHF rats. However, the molecular mechanisms responsible for the sodium channel dysfunction in the baroreceptor neurons from CHF rats remain unknown. We tested the involvement of nuclear factor κB (NFκB) in the sodium channel dysfunction and evaluated the effects of in vivo transfection of manganese superoxide dismutase gene and NFκB shRNA on the baroreflex function in CHF rats. CHF was developed at 6 to 8 weeks after left coronary artery ligation in adult rats. Western blot and chromatin immunoprecipitation data showed that phosphorylated NFκB p65 and ability of NFκB p65 binding to the sodium channel promoter were increased in the nodose ganglia from CHF rats. In vivo transfection of adenoviral manganese superoxide dismutase gene or lentiviral NFκB p65 shRNA into the nodose ganglia partially reversed CHF-reduced sodium channel expression and cell excitability in the baroreceptor neurons and improved CHF-blunted arterial baroreflex sensitivity. Additionally, transfection of adenoviral manganese superoxide dismutase also inhibited the augmentation of phosphorylated NFκB p65 in the nodose neurons from CHF rats. The present study suggests that superoxide-NFκB signaling contributes to CHF-induced baroreceptor dysfunction and resultant impairment of baroreflex function. (Hypertension.
of NFκB. 15 In the resting state, NFκB presents a silent form in the cytosol through tight binding to the specific inhibitor of κBα (IκBα). 11, 15 On activation by various stimuli, including reactive oxygen species, IκB kinase-β (IKKβ) induces the phosphorylation and degradation of IκBα. [16] [17] [18] [19] [20] Then, the liberated NFκB is phosphorylated, leading to nuclear translocation and binding to specific sites on DNA, finally regulating gene transcription. 11, 17 Although many studies have focused on the role of NFκB in target gene transcription, few studies have considered the involvement of NFκB in regulating ion channel gene transcription. Shang et al 21 found that NFκB can directly bind to the SCN5A promoter, which is involved in the angiotensin II/hydrogen peroxide-induced downtranscription of the Na v 1.5 channels. We hypothesized that NFκB could mediate superoxide-lowered expression and activation of Na v channels in the baroreceptor neurons from CHF rats. In the current study, we first measured expression of the IKK-IκB-NFκB signaling in the nodose ganglia from sham and CHF rats and then analyzed the effect of in vivo lentiviral NFκB p65 shRNA or adenoviral manganese superoxide dismutase (Ad.MnSOD) gene transfection on the Na v channels and cell excitability in the baroreceptor neurons from sham and CHF rats. Finally, we evaluated the role of superoxide-NFκB signaling in the baroreflex sensitivity in sham and CHF rats.
Methods
All experimental procedures were approved by the University of Nebraska Medical Center's Institutional Animal Care and Use Committee and were carried out in accordance with the National Institutes of Health Guide for the Care and Use of Laboratory Animals. Male Sprague-Dawley rats weighing 180 to 200 g were assigned randomly to 1 of 2 groups: sham (n=95) and CHF (n=92). CHF was produced by surgical ligation of the left coronary artery, as previously described. 9, 10 CHF was confirmed by hemodynamic and morphological characteristics (Table S1 in the online-only Data Supplement). The key experimental procedures included induction of CHF, in vivo gene or shRNA transfection using adenovirus or lentivirus, Western blot analysis, chromatin immunoprecipitation assay, labeling of aortic baroreceptor neurons and isolation of nodose neurons, recording of Na v currents and action potential in aortic baroreceptor neurons, measurement of superoxide production, and measurement of arterial baroreflex sensitivity. The efficacy of the virus infection was confirmed by the expression of enhanced green fluorescent protein ( Figure S1 in the online-only Data Supplement). Detailed procedures are available in the onlineonly Data Supplement.
Statistical Analysis
All data are presented as means±SEM. SigmaPlot 12 was used for data analysis. Student unpaired t test or 2-way ANOVA with post hoc Bonferroni test was used to determine statistical significance. Statistical significance was accepted when P<0.05.
Results

Expression of IKK-IκB-NFκB Signaling Cascade
Protein levels of IKK complex, IκBα, and NFκB p65 in the nodose ganglia from sham and CHF rats are shown in Figure 1 . There is no significant difference in total IKKα and phosphorylated IKKα between sham and CHF rats. Protein level of the phosphorylated IKKβ was increased by CHF although CHF did not affect expression of the total IKKβ. Additionally, CHF increased the phosphorylated IκB protein and decreased the total IκB protein in the nodose ganglia. Furthermore, we found that the phosphorylated NFκB p65 protein was enhanced in the nodose ganglia from CHF rats. However, CHF did not induce alteration of the total NFκB p65 protein in the nodose ganglia (P>0.05 versus sham).
NFκB p65 Binding to Na v 1.7 Promoter, and Expression and Activation of Na v 1.7 Channels
Because NFκB p65 can bind and regulate many gene expressions, we used chromatin immunoprecipitation technique to examine the ability of NFκB p65 binding to the Na v 1.7 channel promoter for evaluating the role of NFκB p65 in the expression of the Na v 1.7 channels. As illustrated in Figure 2A and Figure S2 , the ability of NFκB p65 binding to the Na v 1.7 channel promoter was increased in the nodose ganglia from CHF rats. Simultaneously, expression of the Na v 1.7 protein and Na v 1.7 currents were reduced in the nodose neurons from CHF rats, compared with sham rats ( Figure 2B and 2C). These data suggest that enhancement of the phosphorylated NFκB p65 protein might be linked to the lower expression of the Na v 1.7 channel protein in the nodose ganglia from CHF rats.
Effect of NFκB p65 shRNA Transfection on Na v 1.7 Currents and Action Potential in the Aortic Baroreceptor Neurons
To further confirm the relationship between NFκB p65 and Na v 1.7 channels, we in vivo transfected lentiviral NFκB p65 shRNA into the nodose ganglia and measured the alterations of the NFκB p65 and Na v 1.7 channels in the nodose ganglia from sham and CHF rats. In sham rats, lentiviral NFκB p65 shRNA (2 µL; 3×10 6 ifu/ mL) decreased expression of the NFκB p65 protein but did not affect expression of the phosphorylated NFκB p65 and Na v 1.7 channel proteins in the nodose ganglia ( Figure 3A) . In CHF rats, lentiviral NFκB p65 shRNA significantly reduced level of the NFκB p65 and phosphorylated NFκB p65 proteins. However, it increased expression of the Na v 1.7 channel protein in the nodose ganglia, compared with those in the noninfected CHF rats ( Figure 3A) .
The Na v 1.7 currents were measured in the aortic baroreceptor neurons from each group ( Figure 3B ). The aortic baroreceptor neurons were identified by Dil retrograde labeling ( Figure S3 ). The Na v 1.7 current was lower in A-and C-type aortic baroreceptor neurons from CHF rats compared with sham rats. Lentiviral NFκB p65 shRNA markedly increased the Na v 1.7 currents in A-and C-type aortic baroreceptor neurons from CHF rats but not in sham neurons ( Figure 3B ).
We measured current threshold-inducing action potential and frequency of action potentials to investigate the role of NFκB p65 in cell excitability of the aortic baroreceptor neurons from sham and CHF rats. Previously, we showed that cell excitability of the aortic baroreceptor neurons was lower Figure 2 . Ability of nuclear factor κB (NFκB) p65 binding to Na v 1.7 promoter (A), and expression (B) and currents (C) of Na v 1.7 channels in sham and chronic heart failure (CHF) rats. A, Ability of NFκB p65 binding to Na v 1.7 promoter was measured using chromatin immunoprecipitation assay. Nodose ganglia from 4 rats were pooled to obtain sufficient tissue for assay. n=12 rats in each group. B, Na v 1.7 channel protein in nodose ganglia was measured by Western blotting. n=5 rats in each group. C, Na v 1.7 current density in aortic baroreceptor neurons was measured by whole-cell patch clamp technique. n=12 cells from 5 rats in each group. Data are means±SEM. *P<0.05 vs sham. Na v indicates voltage-gated sodium. (including higher current threshold-inducing action potential and lower frequency of action potentials) in CHF rats compared with sham rats. 9, 10 In the present study, we observed similar results ( Figure 3C ). In vivo transfection of lentiviral NFκB p65 shRNA into the nodose ganglia of CHF rats significantly increased frequency of action potentials and decreased current threshold-inducing action potential in A-and C-type aortic baroreceptor neurons, compared with the aortic baroreceptor neurons from noninfected CHF rats. Lentiviral NFκB p65 shRNA had no effect on cell excitability of the A-and C-type aortic baroreceptor neurons from sham rats ( Figure 3C ).
We also measured the effect of lentiviral control (scrambled) shRNA (2 µL; 3×10 6 ifu/mL) on aforementioned parameters in sham and CHF rats. Lentiviral control shRNA did not affect the protein expression, Na v 1.7 currents, and cell excitability in sham and CHF rats ( Figure S4 ).
Effect of MnSOD Gene Transfection on Superoxide Production, Expression of NFκB, and Electrophysiological Properties
Expression of MnSOD protein was decreased and superoxide production was increased in the nodose ganglia from CHF rats compared with sham rats ( Figure 4A and 4B), consistent with data from our previous study. 10 In vivo transfection of Ad.MnSOD gene (2 μL; 2×10 10 pfu/mL) into the nodose ganglia caused an increase in the MnSOD protein in the nodose ganglia from sham and CHF rats, compared with that in the noninfected (control) sham and CHF rats ( Figure 4A ). Ad.MnSOD gene transfection decreased total superoxide and mitochondria-derived superoxide levels in the nodose ganglia from CHF rats but not in sham rats ( Figure 4B ). Additionally, Ad.MnSOD gene transfection also reduced the phosphorylated NFκB p65 protein and enhanced the Na v 1.7 protein in the nodose ganglia from CHF rats but not in sham rats ( Figure 4A ).
In vivo Ad.MnSOD gene transfection markedly augmented the Na v 1.7 currents in the A-and C-type aortic baroreceptor neurons from CHF rats but not in sham rats ( Figure 4C ). Similarly, in vivo Ad.MnSOD gene transfection increased the cell excitability (including increasing the frequency of action potentials and lowering the current threshold-inducing action potential) in the A-and C-type aortic baroreceptor neurons from CHF rats but not in sham rats ( Figure 4D ).
However, after in vivo transfection of Ad.empty (2 μL; 2×10 10 pfu/mL) into the nodose ganglia, the protein expression, superoxide production, Na v 1.7 currents, and cell excitability were not altered in the nodose neurons from sham and CHF rats, compared with the noninfected sham and CHF rats ( Figure S5 ).
Effect of NFκB p65 shRNA or MnSOD Gene Transfection on Arterial Baroreflex Sensitivity
Reflex changes in blood pressure and heart rate in response to different electric stimulation of the aortic depressor nerve were used as the indices of the aortic baroreflex sensitivity in each experimental group. As indicated in Figure S6 (representative recordings) and Figure 5 (mean data), reflex decreases in blood pressure and heart rate were attenuated in CHF rats compared with sham rats. Local transfection of lentiviral NFκB p65 shRNA or Ad.MnSOD gene into the nodose ganglia partially increased the blood pressure and heart rate response to electric stimulation of the aortic depressor nerve in CHF rats. The lentiviral NFκB p65 shRNA and Ad.MnSOD gene did not show any effect in sham rats ( Figure 5 ). In vivo transfection of lentiviral control shRNA or Ad.empty into the nodose ganglia did not affect the aortic baroreflex sensitivity in sham and CHF rats ( Figure S7 ).
Another measurement for evaluating the arterial baroreflex, arterial blood pressure changes induced by phenylephrine and attendant reflex responses of heart rate, and cardiac sympathetic nerve activity is shown in Figures S8 and S9. The reflex responses of heart rate and cardiac sympathetic nerve activity to arterial pressure changes in CHF rats were reduced compared with sham rats. The maximum gain of baroreflex control of heart rate and cardiac sympathetic nerve activity in CHF rats was decreased compared with sham rats ( Figure S9 ). These results demonstrated that the arterial baroreflex function was attenuated in CHF rats. Local transfection of lentiviral NFκB p65 shRNA or Ad.MnSOD gene into the nodose ganglia partially restored the arterial baroreflex function in CHF rats compared with that in noninfected CHF rats. However, lentiviral NFκB p65 shRNA or Ad.MnSOD gene did not induce the change of the arterial baroreflex function in sham rats compared with the noninfected sham rats ( Figure S9 ). Local transfection of lentiviral control shRNA or Ad.empty into the nodose ganglia did not alter the baroreflex gain in sham and CHF rats (data not shown).
Discussion
Our present study demonstrates that CHF activates the IKK-IκB-NFκB signaling pathway in the nodose ganglion tissue. The activation of IKK-IκB-NFκB signaling causes reduced Na v channel activity and resultant arterial baroreflex dysfunction in CHF rats. This occurs because NFκB p65 shRNA significantly increases the Na v 1.7 current density and cell excitability of the aortic baroreceptor neurons and improves the arterial baroreflex sensitivity in CHF rats through reducing protein level of the NFκB p65. Our experiments also show that superoxide overproduction activates the NFκB p65 and subsequently induces the alterations of Na v 1.7 currents, cell excitability of the aortic baroreceptor neurons, and arterial baroreflex sensitivity in CHF rats. Together, these results suggest that activation of the superoxide-sensitive transcription factor NFκB is a possible mechanism by which CHF reduces the Na v current density and cell excitability of the aortic baroreceptor neurons and attenuates the arterial baroreflex sensitivity.
NFκB is a family of transcription factors that is normally silent in the cytoplasm through interaction with inhibitory molecules of the IκB family. 11, 15 In response to multiple stimuli in pathophysiological conditions, the IκB molecules are phosphorylated on Ser32 and Ser36 residues by activation of the IKKβ kinases. 16, 17 The serine-phosphorylated IκB is ubiquitinated and degraded. 17, 18 As a consequence, NFκB is activated and translocated from the cytoplasm to the nucleus and finally induces transcription of numerous target genes. 11, 17 In our present study, the IKK-IκB-NFκB signaling pathway exists in rat nodose ganglion tissue. CHF increased the phosphorylated IKK, degraded the IκBα, and enhanced the phosphorylated NFκB p65 in the nodose ganglion tissue. Our present study also found that CHF enhanced the ability of NFκB p65 binding to the Na v 1.7 promoter in the nodose ganglion tissue. These results provide the molecular evidence that activation of the NFκB p65 might be associated with the changes of the Na v 1.7 channel in the nodose neurons (including the aortic baroreceptor neurons) from CHF rats. Compared with the common activation of gene transcription with NFκB binding, however, NFκB overactivation downregulates the Na v 1.7 protein expression and current density in the nodose neurons from CHF rats because transfection of NFκB p65 shRNA normalizes the phosphorylated NFκB p65 and partially increases the Na v 1.7 protein expression and current density in CHF rats. This is in agreement with another study 21 that demonstrated that NFκB can directly bind to the SCN5A promoter, which is involved in downtranscription of the Na v 1.5 channel in rat ventricular cells. Our previous study has shown that blunted expression and activation of the Na v channels lowers the baroreceptor neuron excitability and contributes to impairment of the arterial baroreflex. 9 In the current study, NFκB p65 shRNA significantly improves the aortic baroreceptor neuron excitability and arterial baroreflex sensitivity in CHF rats. These data indicate that activation of NFκB signaling is involved in CHF-induced lower expression of the Na v 1.7 channels, attenuation of the aortic baroreceptor neuron excitability, and impairment of the arterial baroreflex. However, our present study cannot answer why and how activation of the NFκB downregulates expression of the Na v 1.7 channels in the nodose ganglion tissue. Future studies should address these questions.
In our previous study, in vitro transfection of Ad.MnSOD into the isolated primary nodose neurons reduced CHFinduced elevation of the mitochondrial superoxide level in the nodose neurons and partially reversed CHF-decreased Na v channel activation and cell excitability in the aortic baroreceptor neurons. 10 In our present study, in vivo transfection of Ad.MnSOD into the nodose ganglion tissue not only partially increased function of the aortic baroreceptor neurons (including Na v 1.7 channel activation and neuron excitability) but also improved the arterial baroreflex sensitivity in CHF rats. These results further confirmed that impairment of the aortic baroreceptor neurons contributes to the arterial baroreflex dysfunction in CHF rats. Additionally, our present study found that in vivo transfection of Ad.MnSOD also inhibited CHF-induced augmentation of the phosphorylated NFκB p65 in the nodose ganglion tissue ( Figure 4A ). Furthermore, in vivo transfection of NFκB p65 shRNA did not affect the superoxide level in the nodose ganglia from CHF rats (data not shown), which indicates that inhibition of the NFκB p65 improves the aortic baroreceptor function and arterial baroreflex sensitivity even if a high level of the superoxide is preserved in the nodose ganglia from CHF rats. Based on our results, we consider that superoxide overproduction-induced impairment of the aortic baroreceptor neurons and arterial baroreflex dysfunction in CHF rats is the result of activation of the NFκB p65.
The mechanism by which superoxide induces the activation of NFκB p65 in the nodose neurons from CHF rats is not known. In human endothelial cells, protein kinase C is involved in superoxide-induced activation of the NFκB. 22 Mendes et al 23 reported that superoxide mediates interleukin-1β-induced IκBα degradation and consequent NFκB activation in bovine articular chondrocytes. Superoxide is correlated with NFκB activation also via the IKK pathway. 17 In our present study, CHF increased the phosphorylated IKKβ, decreased the total IκBα, and enhanced the phosphorylated NFκB p65 in the nodose neurons ( Figure 1 ). Therefore, it is possible that superoxide regulates activation of the NFκB p65 in the nodose neurons from CHF rats via multiple signal transduction pathways. Further study is needed to clarify this issue.
Our previous study has shown that decreased expression and activation of the Na v channels attenuate the aortic baroreceptor neuron excitability and subsequently impair the arterial baroreflex in CHF rats. 9 Thus far, 9 α-subunits (Na v 1.1-1.9) of the Na v channels have been functionally characterized. They have also been separated by their sensitivity to tetrodotoxin (TTX) into low activation threshold, fast activating, and inactivating TTX-sensitive Na v channels (Na v 1.1, Na v 1.2, Na v 1.3, Na v 1.4, Na v 1.6, and Na v 1.7); and high activation threshold, slow activating, and inactivating TTX-resistant Na v channels (Na v 1.5, Na v 1.8, and Na v 1.9). [24] [25] [26] Each Na v channel subunit has particular tissue localization, consistent with a distinct role for each Na v channel subunit in mammalian physiology. 26 Na v 1.7 (TTX-sensitive), Na v 1.8 (TTX-resistant), and Na v 1.9 (TTX-resistant) are abundantly expressed in the primary sensory neurons, such as the nodose neurons. 9, 25, [27] [28] [29] In the present study, we only measured the regulating role of superoxide-NFκB signaling in the Na v 1.7 channels in the rat nodose neurons because the Na v 1.7 channels are expressed in all nodose neurons (A-and C-type nodose neurons) as a predominant Na v channel α-subunit, but the Na v 1.8 and Na v 1.9 channels are located only in C-type nodose neurons. 9 However, we realize the Na v 1.8 and Na v 1.9 channels in the nodose neuron may have an important role. Thus, future study should also focus on the influence of superoxide-NFκB signaling on the Na v 1.8 and Na v 1.9 channels in CHF state, although there are no reports of the NFκB binding sites on rat Na v 1.8 and Na v 1.9 channel promoters.
One widely accepted method for evaluating the arterial baroreflex is to examine the changes in blood pressure and heart rate induced by electric stimulation of baroreceptorcontaining nerve (aortic depressor nerve). [30] [31] [32] [33] The advantages for this method include the following: (1) rat aortic depressor nerves do not contain a functionally significant number of chemoreceptor afferent fibers for generation of chemoreflex, 34 although morphological evidence has demonstrated that ≈15% of fibers in rat aortic depressor nerves are chemoreceptor afferent fibers 35 ; (2) direct electric stimulation of the aortic depressor nerve bypasses the mechanoviscoelastic coupling between changes in the aortic arterial vascular walls and afferent nerve endings; (3) easily changing the frequency and intensity of stimulus can differentiate the reflex responses to activating A-and C-afferent fibers. However, a disadvantage of the electric stimulation technique is that it does not represent a physiological substrate for baroreceptor activation.
Another method for evaluating the arterial baroreflex is to measure reflex changes in heart rate and cardiac sympathetic nerve activity in response to changes in arterial blood pressure. This measurement uses a physiological stimulation (changes in arterial blood pressure) to activate the arterial baroreflex. A major limitation in this approach is that possible alterations in the mechanotransduction process at the barosensory nerve terminal may also play a role in the baroreflex function in response to blood pressure changes. Thus, the results from either of the 2 measurements need to be tempered by the limitations. Nevertheless, our present study used the 2 methods for evaluation of the arterial baroreflex. We were able to more clearly describe a functional role for alterations in superoxide-NFκB-Na v channel in aortic baroreceptor neurons in CHF by combining reflex effects with stimulation of baroafferents in response to both electric stimulation of aortic depressor nerve and blood pressure change.
Although we measured changes of the Na v 1.7 currents and action potentials in the aortic baroreceptor neurons, we performed biochemical analyses in whole nodose ganglia. We found that CHF induced significant biochemical alterations in the nodose ganglia. Because aortic baroreceptor neurons are a small population of nodose neurons, it is likely that CHF-induced biochemical changes may also occur in other type of nodose neurons. Whether these changes affect other vagal afferent reflexes in CHF rats should be evaluated in future studies.
Perspective
Dysfunction of baroreceptor neurons in the nodose ganglia results in arterial baroreflex impairment, a complication of CHF. Lower expression of Na v channels causes suppression of the baroreceptor neurons in CHF rats. The precise mechanism of the reduced expression of the Na v channels in the baroreceptor neurons is unclear. In the present study, we found that in vivo transfection of MnSOD gene or NFκB p65 shRNA into the nodose ganglia increased expression of the Na v channels, enhanced cell excitability of the baroreceptor neurons, and improved the arterial baroreflex function in CHF rats. The data in the present study can extend our understanding of the mechanisms responsible for impaired arterial baroreflex in CHF and unveil pharmacological and genomic targets for improving arterial baroreflex function and reducing mortality in CHF. What Is New?
• Chronic heart failure (CHF) induces activation of nuclear factor κB (NFκB) in nodose neurons.
• Superoxide-NFκB signaling is involved in CHF-reduced expression of the Na v channels in the baroreceptor neurons.
• In vivo transfection of manganese superoxide dismutase gene or NFκB shRNA improves baroreflex function in CHF.
What Is Relevant?
• Superoxide-NFκB signaling in the baroreceptor neurons plays a major role in the blunted baroreflex in CHF.
• This study provides a new strategy to normalize the arterial baroreflex dysfunction and to reduce mortality in CHF.
Summary
Overactivation of superoxide-sensitive NFκB downregulates cell excitability of the aortic baroreceptor neurons and consequently triggers impairment of the baroreflex function in CHF. 
Novelty and Significance
Methods
Chronic heart failure (CHF) animal model Male Sprague-Dawley rats weighing 180-200 g were assigned randomly to one of two groups: CHF (n=92) and sham (n=95). The CHF rats were anesthetized with isoflurane (Butler Schein Animal Health, Dublin, OH) at 2% for surgical ligation of the left coronary artery, just below its exit from the aorta, between the pulmonary artery outflow tract and left atrium, as previously described. 1 Sham rats underwent the same surgery but the coronary artery was not tied. [1] [2] [3] The degrees of left ventricular dysfunction and heart failure were determined using both hemodynamic and anatomic criteria. On the day of the terminal experiment (6-8 weeks after the coronary artery ligation), each rat was anesthetized again (800 mg/kg urethane and 40 mg/kg chloralose, i.p.), and the trachea was cannulated to facilitate mechanical respiration. Animal body temperature was kept at 37ºC with a heating pad. Right femoral vein was cannulated with a polyethylene-50 catheter for the administration of drugs. Left femoral artery was cannulated with a polyethylene-50 catheter for blood pressure (BP) and heart rate (HR) monitoring. Left ventricular end-diastolic pressure (LVEDP) was measured using a Millar pressure transducer (SPR 524; size, 3.5-Fr; Millar Instruments, Houston, TX). Heart/lung-to body weight ratios were measured. To measure infarct size, the heart was dissected and the atria and right ventricle were removed. A digital image of the left ventricle was captured using a digital camera (Canon, Japan). Infarct size was determined using a colorimetric technique coupled to a computerized planimetric analysis (Adobe Photoshop CS5). The percentage of infarct size to total left ventricle was quantified using Adobe Photoshop CS5 Extended (Adobe Systems Incorporated, CA). Rats with both left ventricular end-diastolic pressure (LVEDP) >15 mmHg and infarct size >30% of total left ventricle were considered as CHF. The hemodynamic and morphological characteristics of sham and CHF rats are summarized in Table  s1 .
Microinjection of manganese superoxide dismutase (MnSOD) gene and NFκB p65 shRNA into nodose ganglia
Rats were anesthetized with 2% isoflurane. Using sterile technique, both nodose ganglia were exposed via a small incision in the cervical region. Under the microscope, the adenoviral MnSOD (Ad.MnSOD) gene (2µl, 2x10 10 pfu/ml, University of Iowa, Iowa City,IA), lentiviral NFκB p65 shRNA (2 µl, 3 x10 6 ifu/ml, Santa Cruz, CA), or their vector were microinjected into both nodose ganglia using a glass micropipette connected to a microinfusion pump (Nanoliter 2000 injector, World Precision Instruments, FL). After transfection, the incision was closed and the experiments were performed 1 week later to guarantee the protein overexpression for gene transfer experiments or degradation of existing protein for shRNA experiments. The efficacy of the virus infection was confirmed by the expression of enhanced green fluorescent protein (EGFP). Rat nodose ganglion was isolated and serially cut into 20-µm-thick sections and then mounted on precoated glass slides for the measurement of EGFP image under a Leica fluorescent microscope with corresponding filters (Leica Microsystems, Buffalo Grove, IL). As shown in Fig. s1 , almost all nodose ganglion neurons were infected by virus, which documented the feasibility of our method for gene or shRNA in-vivo transfection into the nodose ganglia.
Western blot analysis
Nodose ganglia were rapidly removed, immediately frozen in liquid nitrogen, and stored at -80°C until analyzed. Homogenates were prepared from the NG samples and the proteins were extracted with a lysing buffer (10 mM Tris, 1 mM EDTA, 1% SDS; pH 7.4) plus protease inhibitor cocktail (100 µl/ml, Sigma). After centrifugation at 12,000 g for 20 min at 4°C, the protein concentration in the supernatant was determined using a bicinchoninic acid protein assay kit (Pierce, Rockford, IL). The protein samples were mixed with the same volume of the loading buffer and heated at 100°C for 5 min. Equal amounts of the protein samples were loaded and then separated on a 7.5% sodium dodecyl sulfate (SDS)-polyacrylamide gel. The proteins of these samples were electrophoretically transferred at 300 mA for 1.5 h onto PVDF membranes (Millipore Corporation, Billerica, MA). The membranes were blocked with 5% non-fat milk in tris-buffered saline-tween 20, and probed at room temperature with rabbit primary antibodies against IKK, IκB, NFκB, MnSOD (Santa Cruz, CA), Na v 1.7 channel(Alomone Labs, Jerusalem, Israel), respectively. After washing, the membranes were incubated for 1 h with peroxidase-conjugated appropriate secondary antibodies (Pierce Chemical, Rockford, IL). The signal was detected using enhanced chemiluminescence substrate (Pierce Chemical, Rockford, IL) and the bands were analyzed using UVP bioimaging system (UVP, Upland, CA). The blot was reprobed with mouse anti-GADPH antibody (Santa Cruz, CA), allowing normalization of target protein intensity to that of GADPH.
Chromatin immunoprecipitation (ChIP) assay for NFκB p65 binding to Na v 1.7 channel promoter
The ChIP assay was performed using ChIP EpiTect® ChIP OneDay Kit (QIAGEN) and following the manufacturer's protocol. The nodose ganglia were chopped into small pieces and cross-linked using 1% formaldehyde at room temperature for 30 min. The cross-linking reaction was stopped by adding 0.55 ml of glycine at room temperature for 5 min. After washing 3 times with ice-cold PBS buffer, the fixed tissue was homogenated in 150 µl of immunopreciptation lysis buffer with protease inhibitor cocktail, and then sonicated at 4 o C to shear chromatin into about 500 bp. The sonicated sample was centrifuged at 14000 g for 10 min at 4 o C. The supernatant (chromatin) was transferred into a new tube and stored at -80 o C until analyzed.
The chromatin was precleared by protein-A-beads and the cleared chromatin was incubated with NFκB p65 antibody or nonspecific IgG (Millipore) overnight at 4˚C. Immunoprecipitated chromatin complexes were washed to remove from protein-A-beads. Then cross-linking of immunoprecipitated chromatin was reversed by ChIP-Grade proteinase K to obtain the isolated DNA. The isolated DNA was purified into the ChIP DNA for PCR analysis.
4
PCR reaction was performed in a 25 µl volume containing 12.5 µl iQ Syber Green Supermix (Bio-Rad, CA), 300 nM Na v 1.7 primer (GPR1074093(+)01A based on the cDNA sequence of Na v 1.7 channel, NM_133289.1, QIAGEN), and 5 µl ChIP DNA. Negative control samples were taken from the aspiration buffer without ChIP DNA. ChIP DNA was amplified by real-time quantitative PCR with an ABI StepOnePlus Real-Time PCR System (Applied Biosystems, Foster City, CA). After 10 min of denaturation at 95°C, the amplification was performed with 40 thermal cycles of 95°C for 15 sec, 60°C for 1min. For quantification, NFκB binding Na v 1.7 DNA was normalized to the input DNA. The data were analyzed by the 2 -∆∆Ct method.
Labeling of aortic baroreceptor neurons and isolation of nodose neurons
Aortic baroreceptor neurons in the nodose ganglia were selectively retrogradelabeled by a transported fluorescent dye, DiI (red color, Molecular Probes, Eugene, OR) as described previously. 4, 5 Briefly, under sterile condition, rats were anesthetized with isoflurane at 2% for a thoracotomy at the 3 rd intercostal space, and DiI (2 µl) was injected into the adventitia of the aortic arch with a fine-tipped glass pipette. After the application of the dye, the surgical incision was closed. After a one-week recovery period to allow the dye to diffuse to the aortic baroreceptor neurons in the nodose ganglia, the nodose neurons were isolated by two-step enzymatic digestion protocol. 4 The nodose ganglia were dissected free and incubated for 30 min at 37 o C in an enzymatic Ringer's solution containing 0.1% collagenase/0.1% trypsin. The tissues were then transferred to a Ringer's solution containing 0.2% collagenase and 0.5 % bovine serum albumin for a 30 min incubation at 37 o C. The isolated cells were resuspended in culture medium and plated onto culture wells. The culture medium consisted of a 50/50 mixture of Delbecco's modified Eagle's medium (DMEM) and Ham's F12 medium (Gibco, Grand Island,NY) supplemented with antibiotics and 10% fetal bovine serum (Gibco, Grand Island,NY). The nodose neurons were cultured at 37 o C in a humidified atmosphere of 95% air-5% CO 2 for 4-7 h before the experiments.
Recording of Na v currents and action potential
In order to identify the nodose neurons that were successfully transfected gene or shRNA on the recording experiments, we injected combination of Ad.MnSOD plus Ad.EGFP (University of Iowa, Iowa City,IA) or mixture of lentiviral NFκB p65 shRNA plus lentiviral EGFP (Santa Cruz, CA) into nodose ganglia, respectively. The expression of EGFP (green color) was used to confirm the successful transfection of Ad.MnSOD or lentiviral NFκB p65 shRNA . The feasibility of this co-transfection method has been documented by other groups. 6, 7 DiI-labeled nodose neurons (aortic baroreceptor neurons) in nontransfected rats, and both EGFP and Dil-labeled nodose neurons (transfected aortic baroreceptor neurons, Fig. s3) were selected for the recording of Na v currents and action potential. ) is sufficiently large to saturate the patch clamp amplifier. 8 Series resistance of 5-13 MΩ was electronically compensated 30-80%. Junction potential was calculated to be +9.9 mV using pCLAMP 10.2 software and all values of membrane potential given throughout were corrected using this value. Current traces were sampled at 10 kHz and filtered at 5 kHz. The holding potential was -100 mV and current-voltage (I-V) relationships were elicited by 10 mV step increments to potentials between -90 and 40 mV for 40 ms. Peak currents were measured for each test potential and current density was calculated by dividing peak current by cell membrane capacitance. The cell was exposed to 1 µM tetrodotoxin (TTX) in the extracellular bath and the test protocol was repeated, which separates TTX-sensitive (Na v 1.7) and TTXresistant (Na v 1.8 and Na v 1.9) currents. The Na v current inhibited by TTX was defined as TTX-sensitive current and the remaining Na v current as TTX-resistant current.
In the current-clamp experiments, action potential was elicited by a ramp current injection of 0-250 pA and the current threshold-inducing action potential was measured at the beginning of the 1 st action potential. Frequency of action potentials was measured in a 1-sec current clamp. The patch pipette solution was composed of (in mM): 105 K-aspartate, 20 KCl, 1 CaCl 2 , 5 MgATP, 10 HEPES, 10 EGTA, and 25 glucose (pH 7.2; 320 mOsm/L). The bath solution was composed of (in mM): 140 NaCl, 5.4 KCl, 0.5 MgCl 2 , 2.5 CaCl 2 , 5.5 HEPES, 11 glucose, and 10 sucrose (pH 7.4; 330 mOsm/L). P-clamp 10.2 program (Axon Instruments) was used for data acquisition and analysis. All experiments were done at room temperature.
A-type and C-type aortic baroreceptor neurons were identified as previous study.
1 Briefly, after data collection, neurons were depolarized at 0 mV from holding potential -80 mV to record the fast transient sodium currents before and after 1 µM TTX treatment in the extracellular bath. C-type neurons express both TTX-sensitive and TTX-resistant currents but A-type neurons express only TTXsensitive currents. 
Measurement of superoxide production
In order to measure total superoxide production in nodose ganglion samples, nodose ganglia were homogenized in phosphate buffered saline solution at 4°C. Total protein concentration was determined using a bicinchoninic acid protein assay kit (Pierce; Rockford, IL). Total superoxide production was measured using lucigenin chemiluminescence method. [10] [11] [12] [13] The homogenate (0.3 ml) was placed in 0.5 ml microfuge containing dark-adapted lucigenin (5 µM), and then accumulative light emission was recorded for 5 min in a TD-20/20 Luminometer (Turner Designs, Sunnyvale, CA).
Level of mitochondria-derived superoxide was measured using the mitochondria-targeted, superoxide-sensitive fluorogenic probe MitoSOX Red (Invitrogen, Carlsbad, CA), as previously described.
14 Briefly, the fresh nodose neurons were loaded with MitoSOX Red (1 µM), MitoTracker Green (50 nM, a mitochondria-marker; Invitrogen, Carlsbad, CA), and DAPI for 40 min. The images were captured using a Leica Fluorescent microscope and quantified using Adobe Photoshop CS3 Extended (Adobe Systems Incorporated, CA).
Measurement of baroreflex sensitivity
Rat was anesthetized with a combination of urethane (800 mg kg -1 , i.p.) and chloralose (40 mg kg -1 , i.p.), with supplements of chloralose (10 mg kg -1 , i.v.) per 2 h. After a ventral midline incision was made in the neck, the trachea was cannulated, and rat was artificially ventilated using a mechanical respirator (Harvard Apparatus, 2.5 ml tidal volume and 60 breaths/min). Catheters were implanted into the femoral artery and vein for arterial blood pressure and heart rate measurements and drug administration, respectively.
Left thoracotomy was performed in the second intercostal space. The left stellate ganglion located at the level of cervical vertebrae 7 and anterior to the neck of the first rib was exposed. Left cardiac postganglionic sympathetic nerve was dissected and identified by increases of heart rate and blood pressure in response to the sympathetic nerve stimulation. The cardiac sympathetic nerve was placed on a bipolar platinum recording electrode and covered by Kwik-Cast Silicone elastomer (World Precision Instruments). The cardiac sympathetic nerve activity was amplified using Grass P-55 pre-amplifier (Astro-Med, Inc.). The blood pressure, heart rate, and cardiac sympathetic nerve activity were recorded by LabChart 7 (ADInstruments, Colorado Springs, CO).
Method 1: Baroreflex sensitivity was measured using reflex changes in heart rate and cardiac sympathetic nerve activity in response to changes in arterial blood pressure. The arterial blood pressure was decreased to about 50 mm Hg by sodium nitroprusside (30 µg, i.v.), and then increased by phenylephrine (10 µg, i.v.). The logistic regression curve was fit by the following equation: heart rate or cardiac sympathetic nerve activity = A/{1 + exp [B (blood pressure -C)]} + D, where A is heart rate or cardiac sympathetic nerve activity range, B is the slope coefficient, C is the pressure at the midpoint of the range, and D is minimum heart rate or cardiac sympathetic nerve activity. 15 As the index of baroreflex sensitivity, the peak slope (or maximum gain) was determined by A * B/4 of the logistic function curve.
Method 2: The responses of blood pressure and heart rate to electrical stimulation of aortic depressor nerve were measured for the evaluation of the baroreflex sensitivity in rats. A 3-5 mm segment of the right aortic depressor nerve was isolated near its junction with the superior laryngeal nerve. The nerve was placed on the stimulating electrodes (bipolar) and covered with mineral oil. All other nerves were intact. Unilateral aortic depressor nerve stimulation was imposed using 10 s of constant-frequency stimulation with 0.1 ms pulse duration and intensity of 18 V, 1-10 Hz (activating C-type afferent fiber) and 10-100 Hz (activating A-and C-type afferent fibers). 16 Reflex changes in blood pressure and heart rate related to different stimulating parameters were used as the indices of baroreflex sensitivity for the A-and C-type baroreflex. 
